Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition.
Rotella V, Fornaro L, Vasile E, Tibaldi C, Boldrini L, Chella A, D'Incecco A, Cirigliano G, Chioni A, Lupi C, Sensi E, Ginocchi L, Giovannelli S, Pennucci MC, Fontanini G, Baldini E. Rotella V, et al. Among authors: chioni a. J Exp Clin Cancer Res. 2014 Oct 11;33(1):77. doi: 10.1186/s13046-014-0077-6. J Exp Clin Cancer Res. 2014. PMID: 25300933 Free PMC article.
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
Tibaldi C, Ricci S, Russo F, Bernardini I, Galli L, Chioni A, Orlandini C, Grosso AM, Pegna AL, Fabbri A, Innocenti F, Ferrari K, Tognarini L, Conte PF, Falcone A; POLTO group. Tibaldi C, et al. Among authors: chioni a. Lung Cancer. 2005 Apr;48(1):121-7. doi: 10.1016/j.lungcan.2004.10.008. Epub 2004 Dec 10. Lung Cancer. 2005. PMID: 15777979 Clinical Trial.
Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.
Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G. Ricci S, et al. Among authors: chioni a. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1023-30. doi: 10.1007/s00259-006-0343-8. Epub 2007 Jan 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17242920
Docetaxel rechallenge in metastatic castration-resistant prostate cancer: any place in the modern treatment scenario? An intention to treat evaluation.
Bracarda S, Caserta C, Galli L, Carlini P, Pastina I, Sisani M, Scali S, Hamzaj A, Derosa L, Felici A, Rossi M, Altavilla A, Chioni A, De Angelis V. Bracarda S, et al. Among authors: chioni a. Future Oncol. 2015 Nov;11(22):3083-90. doi: 10.2217/fon.15.217. Epub 2015 Oct 5. Future Oncol. 2015. PMID: 26437324
FGF signalling facilitates cervical cancer progression.
Mahmood HA, Tomas Bort E, Walker AJ, Grose RP, Chioni AM. Mahmood HA, et al. Among authors: chioni am. FEBS J. 2022 Jun;289(12):3440-3456. doi: 10.1111/febs.16331. Epub 2022 Jan 3. FEBS J. 2022. PMID: 34951738 Free article.
33 results